Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 47.14M
March 31, 2026 47.06M
December 31, 2025 46.74M
September 30, 2025 46.68M
June 30, 2025 38.87M
March 31, 2025 38.80M
December 31, 2024 38.57M
September 30, 2024 38.48M
June 30, 2024 38.40M
March 31, 2024 38.29M
December 31, 2023 38.01M
September 30, 2023 37.84M
June 30, 2023 37.57M
March 31, 2023 37.42M
December 31, 2022 37.09M
September 30, 2022 37.09M
June 30, 2022 36.97M
March 31, 2022 36.90M
December 31, 2021 36.77M
September 30, 2021 36.57M
June 30, 2021 36.45M
Date Value
March 31, 2021 36.29M
December 31, 2020 31.80M
September 30, 2020 31.58M
June 30, 2020 28.11M
March 31, 2020 28.24M
December 31, 2019 28.11M
September 30, 2019 27.97M
June 30, 2019 24.89M
March 31, 2019 22.49M
December 31, 2018 22.37M
September 30, 2018 22.15M
June 30, 2018 21.98M
March 31, 2018 21.82M
December 31, 2017 21.71M
September 30, 2017 21.82M
June 30, 2017 20.75M
March 31, 2017 21.82M
December 31, 2016 21.82M
September 30, 2016 21.82M
June 30, 2016 20.75M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. 37.70M
Codexis, Inc. 91.39M
Frontage Holdings Corp. --
Repligen Corp. 56.43M
Bio-Techne Corp. 156.10M